Antifungal prophylaxis for prevention of COVID-19-associated pulmonary aspergillosis in critically ill patients: an observational study

Abstract Background Coronavirus disease 19 (COVID-19)-associated pulmonary aspergillosis (CAPA) emerged as important fungal complications in patients with COVID-19-associated severe acute respiratory failure (ARF). Whether mould active antifungal prophylaxis (MAFP) can prevent CAPA remains elusive s...

पूर्ण विवरण

ग्रंथसूची विवरण

मुख्य लेखकों:	Stefan Hatzl, Alexander C. Reisinger, Florian Posch, Juergen Prattes, Martin Stradner, Stefan Pilz, Philipp Eller, Michael Schoerghuber, Wolfgang Toller, Gregor Gorkiewicz, Philipp Metnitz, Martin Rief, Florian Prüller, Alexander R. Rosenkranz, Thomas Valentin, Robert Krause, Martin Hoenigl, Gernot Schilcher
स्वरूप:	Artigo
भाषा:	Inglês
प्रकाशित:	BMC 2021-09-01
श्रृंखला:	Critical Care
विषय:	ICU CAPA COVID-19-associated aspergillosis Posaconazole Mould prophylaxis
ऑनलाइन पहुंच:	https://doi.org/10.1186/s13054-021-03753-9
टैग:	टैग जोड़ें कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!